Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2021 Filed Apr 13, 2021 22:40 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 47,580 | $2.12 | $100,883.87 |
DisclosureSEC source: 0001104659-21-049878 · tm2112899d1_4.xml · nonDerivative · entry 4 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 652 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on March 10, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $2.02 to $2.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Shares held directly by Delphi BioInvestments VIII, L.P. ("DBI VIII"). The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of DBI VIII. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by DBI VIII and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by DBI VIII, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 22:40 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 4,906,326 | $2.12 | $10,402,883.02 |
DisclosureSEC source: 0001104659-21-049878 · tm2112899d1_4.xml · nonDerivative · entry 3 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on March 10, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $2.02 to $2.37, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Shares held directly by Delphi Ventures VIII, L.P. ("DV VIII"). The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of DV VIII. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by DV VIII and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by DV VIII, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 22:40 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 46,989 | $2.39 | $112,190.94 |
DisclosureSEC source: 0001104659-21-049878 · tm2112899d1_4.xml · nonDerivative · entry 2 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 48,232 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on March 10, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.30 to $2.565, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Shares held directly by Delphi BioInvestments VIII, L.P. ("DBI VIII"). The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of DBI VIII. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by DBI VIII and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by DBI VIII, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 22:40 UTC |
ROEDER DOUGLAS ADirector
|
SaleCommon Stock | 4,845,399 | $2.39 | $11,568,874.65 |
DisclosureSEC source: 0001104659-21-049878 · tm2112899d1_4.xml · nonDerivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,845,399 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan entered into on March 10, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.30 to $2.565, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Shares held directly by Delphi Ventures VIII, L.P. ("DV VIII"). The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of DV VIII. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by DV VIII and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by DV VIII, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:05 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 7,279 | $2.58 | $18,779.82 |
DisclosureSEC source: 0001209191-21-025217 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218,601 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $18,779.82 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:02 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 4,941 | $2.58 | $12,747.78 |
DisclosureSEC source: 0001209191-21-025208 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,875 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $12,747.78 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:58 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 2,919 | $2.58 | $7,531.02 |
DisclosureSEC source: 0001209191-21-025192 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,334 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,531.02 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 17:00 UTC |
Klein Peter JustinDirector
|
GrantCommon Stock | 2,470 | $2.58 | $6,372.60 |
DisclosureSEC source: 0001209191-21-025193 · doc4.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,186 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,372.60 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:04 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 4,602 | $2.58 | $11,873.16 |
DisclosureSEC source: 0001209191-21-025214 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,275 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $11,873.16 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:08 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 20,190 | $0.93 | $18,780.74 |
DisclosureSEC source: 0001209191-21-002362 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,211,322 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $18,780.74 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:12 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 8,096 | $0.93 | $7,530.90 |
DisclosureSEC source: 0001209191-21-002367 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,415 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,530.90 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:10 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 13,706 | $0.93 | $12,749.32 |
DisclosureSEC source: 0001209191-21-002364 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,934 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $12,749.32 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 19:11 UTC |
Klein Peter JustinDirector
|
GrantCommon Stock | 6,853 | $0.93 | $6,374.66 |
DisclosureSEC source: 0001209191-21-002365 · doc4.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,716 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.66 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:09 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 12,766 | $0.93 | $11,874.93 |
DisclosureSEC source: 0001209191-21-002363 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,673 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $11,874.93 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021. Read SEC document |
| November 15, 2020 Filed May 27, 2021 21:37 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
Tax withholdingCommon Stock | 39,581 | $0.39 | $15,436.59 |
DisclosureSEC source: 0001209191-21-036392 · doc4.xml · nonDerivative · entry 1 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,483 F1 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units ("RSUs"). Read SEC document |
| November 15, 2020 Filed May 28, 2021 01:32 UTC |
Goodnow Timothy TDirector · President and CEO
|
Tax withholdingCommon Stock | 155,511 | $0.39 | $60,649.29 |
DisclosureSEC source: 0001209191-21-036388 · doc4.xml · nonDerivative · entry 1 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,962,421 F1 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units ("RSUs"). Read SEC document |
| November 15, 2020 Filed May 28, 2021 01:34 UTC |
JAIN MukulChief Operating Officer
|
Tax withholdingCommon Stock | 77,039 | $0.39 | $30,045.21 |
DisclosureSEC source: 0001209191-21-036390 · doc4.xml · nonDerivative · entry 1 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,648,096 F1 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units ("RSUs"). Read SEC document |
| November 15, 2020 Filed May 28, 2021 01:35 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 44,293 | $0.39 | $17,274.27 |
DisclosureSEC source: 0001209191-21-036391 · doc4.xml · nonDerivative · entry 1 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,153 F1 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:16 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 48,243 | $0.39 | $18,781.00 |
DisclosureSEC source: 0001209191-20-053857 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191,132 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $18,781 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:18 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 32,751 | $0.39 | $12,749.96 |
DisclosureSEC source: 0001209191-20-053859 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,228 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $12,749.96 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:20 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 19,345 | $0.39 | $7,531.01 |
DisclosureSEC source: 0001209191-20-053862 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,319 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,531.01 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 18:19 UTC |
Klein Peter JustinDirector
|
GrantCommon Stock | 16,375 | $0.39 | $6,374.79 |
DisclosureSEC source: 0001209191-20-053861 · doc4.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,863 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.79 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:17 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 30,503 | $0.39 | $11,874.82 |
DisclosureSEC source: 0001209191-20-053858 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,907 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $11,874.82 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:20 UTC |
Raab Anthony R.Director
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053863 · doc4.xml · nonDerivative · entry 1 Raab Anthony R. · CIK 0001827192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,077 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on October 1, 2021, subject to the reporting person's continuous service through such vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 17:15 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
Disposition to issuerCommon Stock | 36,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043335 · doc4.xml · nonDerivative · entry 2 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 876,064 F3 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of RSUs. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:10 UTC |
Goodnow Timothy TDirector · President and CEO
|
Tax withholdingCommon Stock | 156,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043329 · doc4.xml · nonDerivative · entry 2 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,117,932 F3 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of RSUs. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:12 UTC |
JAIN MukulChief Operating Officer
|
Tax withholdingCommon Stock | 77,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043330 · doc4.xml · nonDerivative · entry 2 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,825,135 F3 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of RSUs. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:13 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
Disposition to issuerCommon Stock | 44,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043333 · doc4.xml · nonDerivative · entry 2 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,446 F3 · shares: Represents shares withheld to satisfy withholding tax obligations upon the vesting of RSUs. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 17:15 UTC |
Panlilio MirasolVP Global Sales and Marketing
|
GrantCommon Stock | 913,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043335 · doc4.xml · nonDerivative · entry 1 Panlilio Mirasol · CIK 0001667551 · VP Global Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913,043 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:10 UTC |
Goodnow Timothy TDirector · President and CEO
|
GrantCommon Stock | 3,836,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043329 · doc4.xml · nonDerivative · entry 1 Goodnow Timothy T · CIK 0001667588 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,273,969 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:12 UTC |
JAIN MukulChief Operating Officer
|
GrantCommon Stock | 1,902,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043330 · doc4.xml · nonDerivative · entry 1 JAIN Mukul · CIK 0001667593 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,902,174 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:09 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043328 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,477 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:07 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043326 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,142,889 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:16 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043336 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,974 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 23, 2020 00:26 UTC |
ROEDER DOUGLAS ADirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043420 · doc4.xml · nonDerivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,077 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 17:14 UTC |
Klein Peter JustinDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043334 · doc4.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,488 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:13 UTC |
Kaufman FrancineDirector · Chief Medical Officer
|
GrantCommon Stock | 1,021,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043333 · doc4.xml · nonDerivative · entry 1 Kaufman Francine · CIK 0001769791 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,739 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:08 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043327 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,404 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 20:38 UTC Amendment |
DeFalco Stephen PDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047741 · doc4a.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,142,889 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 20:43 UTC Amendment |
Fiorentino EdwardDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047744 · doc4a.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,477 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 20:46 UTC Amendment |
Prince Douglas SDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047747 · doc4a.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,974 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 20:47 UTC Amendment |
ROEDER DOUGLAS ADirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047750 · doc4a.xml · nonDerivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,077 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 20:42 UTC Amendment |
Steven EdelmanDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047743 · doc4a.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,404 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 20, 2020 Filed Aug 20, 2020 16:44 UTC Amendment |
Klein Peter JustinDirector
|
GrantCommon Stock | 273,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047745 · doc4a.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,488 F1 · shares: Represents a restricted stock unit ("RSU") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. F2 · shares: This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:49 UTC |
DeFalco Stephen PDirector
|
GrantCommon Stock | 49,804 | $0.38 | $18,781.09 |
DisclosureSEC source: 0001209191-20-040418 · doc4.xml · nonDerivative · entry 1 DeFalco Stephen P · CIK 0001666964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 869,812 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $18,781.09 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:55 UTC |
Fiorentino EdwardDirector
|
GrantCommon Stock | 33,810 | $0.38 | $12,749.75 |
DisclosureSEC source: 0001209191-20-040464 · doc4.xml · nonDerivative · entry 1 Fiorentino Edward · CIK 0001666972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,400 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $12,749.75 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:53 UTC |
Prince Douglas SDirector
|
GrantCommon Stock | 19,971 | $0.38 | $7,531.06 |
DisclosureSEC source: 0001209191-20-040450 · doc4.xml · nonDerivative · entry 1 Prince Douglas S · CIK 0001666995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,897 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $7,531.06 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 17:53 UTC |
Klein Peter JustinDirector
|
GrantCommon Stock | 16,905 | $0.38 | $6,374.88 |
DisclosureSEC source: 0001209191-20-040586 · doc4.xml · nonDerivative · entry 1 Klein Peter Justin · CIK 0001608710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,411 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.88 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:51 UTC |
Steven EdelmanDirector
|
GrantCommon Stock | 31,490 | $0.38 | $11,874.88 |
DisclosureSEC source: 0001209191-20-040432 · doc4.xml · nonDerivative · entry 1 Steven Edelman · CIK 0001683354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,327 F1 · shares: This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $18,874.88 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020. Read SEC document |
| April 29, 2020 Filed Apr 29, 2020 18:00 UTC |
NEW ENTERPRISE ASSOCIATES 10 L P10% owner
NEA PARTNERS 10 L P10% owner
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 144,538 | $0.60 | $87,156.41 |
DisclosureSEC source: 0001209191-20-026216 · doc4.xml · nonDerivative · entry 3 NEW ENTERPRISE ASSOCIATES 10 L P · CIK 0001132326 · 10% owner NEA PARTNERS 10 L P · CIK 0001236049 · 10% owner SANDELL SCOTT D · CIK 0001237289 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,476,414 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6000 to $0.6098, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. F2 · ownership.direct: The shares are directly held by New Enterprise Associates 10, Limited Partnership ("NEA 10") and indirectly held by NEA Partners 10, Limited Partnership ("NEA Partners 10"), the sole general partner of NEA 10, and the individual general partner of NEA Partners 10 (NEA Partners 10 and its individual general partner together, the "Indirect Reporting Persons"). The individual general partner of NEA Partners 10 is Scott D. Sandell. The NEA 10 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the NEA 10 Indirect Reporting Persons have no pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.